Jun 272 minPress Release: Release Therapeutics Announces New CEO to Drive Best-in-Class CNS InnovationRelease Tx Announces New CEO, aligning with the company’s recent pivot towards treating genetic disorders of the CNS without gene therapy
Jun 156 minTreating Genetic Disorders of the CNS without Gene Therapy (or what we’ve been up to here at Release Therapeutics)Release Therapeutics' strategic pivot towards treating genetic disorders of the central nervous system without gene therapy.
Sep 15, 20231 minMaxiVAX transitions into Release TxWe are pleased to announce that, with the recent progress in the development of its unique platform technology, MaxiVAX is morphing into...